Ambulatory prazosin treatment of chronic congestive heart failure: Development of late tolerance reversible by higher dosage and interrupted substitution therapy
- 1 May 1981
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 101 (5), 541-547
- https://doi.org/10.1016/0002-8703(81)90219-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Afterload reduction and cardiac performanceAmerican Journal Of Medicine, 1978
- Long-term outpatient vasodilator therapy of congestive heart failureAmerican Journal Of Medicine, 1978
- Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failureAmerican Journal Of Medicine, 1978
- Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failureThe American Journal of Cardiology, 1978
- Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure.Circulation, 1978
- Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.Circulation, 1977
- Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator PrazosinNew England Journal of Medicine, 1977
- Effects of prazosin on forearm resistance and capacitance vesselsClinical Pharmacology & Therapeutics, 1977
- Physiologic evaluation of a new antihypertensive agent: prazosin HCl.Circulation, 1977
- A simplified plethysmographic system for the measurement of systemic arterial pressure and peripheral blood flowAmerican Heart Journal, 1962